ቤት » ሁሉም » የአክሲዮን ትንበያ » Theravance Biopharma Inc. Ordinary Shares ትንበያ

Theravance Biopharma Inc. Ordinary Shares ትንበያ: ነገ, ሳምንት, ወር, 5 ዓመታት

ተዘምኗል: April 22 · 2026 at 07:03 UTC
▼ -0.60%Market Cap $855.81M · Technical analysis Bearish · Focus area Price + volatility

የትንበያ ማጠቃለያ

የጊዜ ገደብየተገመተው ዋጋያለፈውታሪካዊማስተዋል
ነገ$16.50 -0.71%ትናንት$16.67 +0.30%Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.62 and targets $16.50 (-0.71%). The near-term read is downside; watch $17.12 / $16.12 because daily realized volatility is about 3.65%.
Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.62 and targets $16.50 (-0.71%). The near-term read is downside; watch $17.12 / $16.12 because daily realized volatility is about 3.65%.
ሳምንት$16.25 -2.20%ባለፈው ሳምንት$16.77 +0.92%The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.77 to $16.25 (-2.20%). It gives downside momentum context for this stock, so breaks around $17.12 / $16.12 matter more than a single tick.
The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.77 to $16.25 (-2.20%). It gives downside momentum context for this stock, so breaks around $17.12 / $16.12 matter more than a single tick.
ወር$15.84 -4.69%ባለፈው ወር$16.95 +1.97%The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-4.69%), compared with the live reference near $16.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-4.69%), compared with the live reference near $16.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
አመት$15.22 -8.41%ያለፈው ዓመት$17.21 +3.53%The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.22 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.22 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 ዓመታት$13.77 -17.14%ከ 5 ዓመታት በፊት$17.82 +7.20%The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.77 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.77 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
ነገ$16.50 -0.71%
ትናንት$16.67 +0.30%
Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.62 and targets $16.50 (-0.71%). The near-term read is downside; watch $17.12 / $16.12 because daily realized volatility is about 3.65%.
ሳምንት$16.25 -2.20%
ባለፈው ሳምንት$16.77 +0.92%
The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.77 to $16.25 (-2.20%). It gives downside momentum context for this stock, so breaks around $17.12 / $16.12 matter more than a single tick.
ወር$15.84 -4.69%
ባለፈው ወር$16.95 +1.97%
The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-4.69%), compared with the live reference near $16.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
አመት$15.22 -8.41%
ያለፈው ዓመት$17.21 +3.53%
The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.22 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 ዓመታት$13.77 -17.14%
ከ 5 ዓመታት በፊት$17.82 +7.20%
The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.77 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

የዋጋ ገበታ

ታሪካዊትንበያጉልበተኛተሸካሚ
$17.00$16.73$16.46$16.19$15.921W AgoNow7D F

ቴክኒካዊ ትንተና

መሸጥገለልተኛይግዙ
Bearish
0
ጉልበተኛ
3
ገለልተኛ
2
ተሸካሚ

ቁልፍ አመልካቾች

አመልካችዋጋሲግናል
Price$16.62 Mid
Daily Change-0.60% Below
Volatility Cap20.0% Mid
Confidence58% Below
Data Sourcenasdaq-screener Mid

ታሪካዊ ውሂብ

Current$16.62
Daily Change-0.60%
Market Cap$855.81M
Sourcenasdaq-screener
Current$16.62Daily Change-0.60%
Market Cap$855.81MSourcenasdaq-screener

የድጋፍ እና የመቋቋም ደረጃዎች

$16.12Support 1
$16.62የአሁኑ
$17.12Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

የዋጋ ግስጋሴዎች

ቁልፍ ደረጃዎች እና ታሪካዊ አውድ
Current$16.62Live reference price
Used as the anchor for generated forecast calculations.
Next Month$15.84Model projection-4.69%
Directional scenario based on capped drift.

የትንበያ ትክክለኛነት

የእኛ ሞዴል እንዴት እንዳከናወነ
58%
አቅጣጫዊ
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
የቅርብ ጊዜውን የዋጋ እርምጃ፣ የተለዋዋጭነት አገዛዝ እና ጠቋሚ ምልክቶችን በመጠቀም የእኛ ስልተ ቀመር በየሳምንቱ እንደገና ይስተካከላል። ትክክለኛነት በጊዜ ወሰን ይለያያል - የአጭር ጊዜ መነሳሳት ከረዥም ጊዜ ትንበያዎች የበለጠ አስተማማኝ ነው።
Short term
58%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

የኢንቨስትመንት ሁኔታዎች

ዛሬ $1,000 በTBPH ውስጥ ኢንቨስት ካደረጉ
Bullish Scenario
$17.45
+5.00% from current
የዒላማ ዋጋ$17.45
ሁኔታUpside momentum
ሊሆን ይችላል።50%
Base Scenario
$15.84
-4.69%
የዒላማ ዋጋ$15.84
ሁኔታCapped drift
ሊሆን ይችላል።58%
Bearish Scenario
$15.79
-5.00% from current
የዒላማ ዋጋ$15.79
ሁኔታVolatility drawdown
ሊሆን ይችላል።42%
መሰረት: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

የትንበያ ምክንያቶች

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bearish · 40/100
24H drift-0.71%
7D drift-2.20%
30D drift-4.69%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-Off Caution · 35/100
1M outlook-4.69%
1Y outlook-8.41%
5Y outlook-17.14%

በተደጋጋሚ የሚጠየቁ ጥያቄዎች

Q What is the Theravance Biopharma Inc. Ordinary Shares (TBPH) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Theravance Biopharma Inc. Ordinary Shares is projected near $16.50 versus the current reference around $16.62. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for TBPH?
The weekly Theravance Biopharma Inc. Ordinary Shares model points to $16.25, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Theravance Biopharma Inc. Ordinary Shares 1-month and 1-year targets?
The Theravance Biopharma Inc. Ordinary Shares 1-month target is $15.84 (-4.69%), while the 1-year target is $15.22 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Theravance Biopharma Inc. Ordinary Shares 5-year scenario differ from short-term rows?
The Theravance Biopharma Inc. Ordinary Shares long-horizon scenario sits near $13.77 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are TBPH support and resistance zones right now?
For Theravance Biopharma Inc. Ordinary Shares, nearest resistance is around $16.12, while nearest support is around $17.12. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Theravance Biopharma Inc. Ordinary Shares market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.